期刊
EPIGENOMICS
卷 8, 期 8, 页码 1079-1085出版社
FUTURE MEDICINE LTD
DOI: 10.2217/epi-2016-0035
关键词
EDVs; malignant pleural mesothelioma; mesomiR-1; miRNA; miR-16; targeted delivery
资金
- Translational Program Grant from Cancer Institute NSW [11TPG3-06]
- Cancer Council NSW [RG14-17]
miRNAs are responsible for post-transcriptional control of gene expression, and are frequently downregulated in cancer. It has become well established that restoring miRNA levels can inhibit tumor growth, and many studies have demonstrated this in preclinical models. This in turn has led to the first clinical trials of miRNA replacement therapy. This special report focuses on the development of TargomiRs-miRNA mimics delivered by targeted bacterial minicells-and the very first clinical experience of a miRNA replacement therapy in thoracic cancer patients in the Phase I MesomiR-1 trial.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据